Sivasubramanian Ramakrishnan

Sivasubramanian Ramakrishnan

Auto-generated profile, based on publicly available information

Sivasubramanian Ramakrishnan

Department of Cardiology, All India Institute of Medical Sciences, New Delhi, 110029, India.

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2020 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
BABalaji Arvind
Balaji Arvind
SRSivasubramanian Ramakrishnan
Sivasubramanian Ramakrishnan

1 July 2021 in Annals of Pediatric Cardiology
Verified
Journal Article
Open access
PDF file
SRSivasubramanian Ramakrishnan
Sivasubramanian Ramakrishnan
Ann Pediatr Card, Annals of Pediatric Cardiology is the official publication of The Pediatric Cardiology Society of India .

1 July 2021 in Annals of Pediatric Cardiology
Verified
Journal Article
Open access
PDF file
SSSakshi Sachdeva
Sakshi Sachdeva
SRSivasubramanian Ramakrishnan
Sivasubramanian Ramakrishnan
MCMrigank Choubey
Mrigank Choubey
NKNageswara Rao Koneti
Nageswara Rao Koneti
KMKalaivani Mani
Kalaivani Mani
SRSuresh G Rao
Suresh G Rao
Background : Outcome data of children with heart disease who acquired COVID-19 infection are limited. Aims : We sought to analyze outcome data and identify risk factors associated with mortality in children with heart disease and grown-ups with congenital heart disease (GUCH) who had a laboratory-confirmed COVID-19 infection. Settings and Design : This is a retrospective, multicentric, observational study. Materials and Methods : The study included children with heart disease and GUCH population, who presented with either symptomatic or asymptomatic COVID-19 infection to any of the participating centers. COVID-19-negative patients admitted to these centers constituted the control group. Results : From 24 pediatric cardiac centers across India, we included 94 patients with a median age of 12.5 (interquartile range 3–96) months and 49 (52.1%) patients were males. Majority (83 patients, 88.3%) were children. One-third of the patients (n = 31, 33.0%) had acyanotic congenital heart disease, and 41.5% (n = 39) were cyanotic, with > 80% of the patients being unoperated. Only 30 (31.9%) patients were symptomatic for COVID-19 infection, while the rest were incidentally detected positive on screening. A total of 13 patients died (case fatality rate: 13.8%). The in-hospital mortality rate among hospitalized patients was significantly higher among COVID-19-positive cases (13 of 48; 27.1%) as compared to COVID-negative admissions (9.2%) during the study period (P < 0.001). On multivariate analysis, the independent predictors of mortality among COVID-19-positive cases were severity of illness at admission (odds ratio [OR]: 535.7, 95% confidence interval [CI]: 6.9–41,605, P = 0.005) and lower socioeconomic class (OR: 29.5, 95% CI: 1.1–814.7, P = 0.046). Conclusions : Children with heart disease are at a higher risk of death when they acquire COVID-19 infection. Systematic preventive measures and management strategies are needed for improving the outcomes.

1 May 2024 in Annals of Pediatric Cardiology
Verified
Journal Article
Open access
LKLamk Kadiyani
Lamk Kadiyani
MKMani Kalaivani
Mani Kalaivani
KIKrishna S. Iyer
Krishna S. Iyer
SRSivasubramanian Ramakrishnan
Sivasubramanian Ramakrishnan
Background: The mortality risks of children undergoing various cardiac surgeries for congenital heart disease (CHD) in India are not well defined. We conducted a systematic review and meta-analysis to estimate the inhospital mortality of various common CHD surgeries reported in India and compared it to representative data from established Western databases. Methods and Results: We searched four bibliographic databases for studies published in India over the last 25 years. In total, 135 studies met the inclusion criteria and included 30,587 patients aged from 1 day to 65 years. The pooled mortality rate of 43 Indian studies reporting multiple CHD surgical outcomes is 5.63% (95% confidence interval [CI]: 4.26–7.16; I 2 = 93.9%), whereas the Western data showed a pooled mortality rate of 2.65% (P value for comparison <0.0001). The pooled mortality risk for ventricular septal defect closure and tetralogy of Fallot repair in Indian studies was 2.87% (95% CI: 0.76–5.91; I 2 = 62.4%) and 4.61% (95% CI: 2.0–8.02; I 2 = 87.4%), respectively. The estimated mortality risk was higher than the Western databases for all subcategories studied except for surgeries in the grown-ups with CHD population and coarctation repair. Conclusions: The estimated mortality risks are higher among Indian patients undergoing cardiac surgery for CHD as compared to Western data. We need prospective multicentric data to document whether the observed excess mortality exists after adjusting for various high-risk features and comorbidities in Indian patients. We need systemic measures to improve the outcomes of CHD surgeries in India.

1 October 2016 in Phytomedicine
Verified
Journal Article
Closed access
SMSubir K Maulik
Subir K Maulik
VWVinu Wilson
Vinu Wilson
SSSandeep Seth
Sandeep Seth
BBBalram Bhargava
Balram Bhargava
PDPamila Dua
Pamila Dua
CKChandra K Katiyar
Chandra K Katiyar

19 October 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
NBNarendra Kumar Bagri
Narendra Kumar Bagri
RDRakesh Kumar Deepak
Rakesh Kumar Deepak
SMSuneeta Meena
Suneeta Meena
SGSaurabh Kumar Gupta
Saurabh Kumar Gupta
SPSatya Prakash
Satya Prakash
SKSushil Kumar Kabra
Sushil Kumar Kabra